{"id":"W1978591675","doi":"10.1038/nrc1821","title":"Validating matrix metalloproteinases as drug targets and anti-targets for cancer therapy","year":2006,"lang":"en","type":"review","venue":"Nature reviews. Cancer","topic":"Protease and Inhibitor Mechanisms","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1205,"is_retracted":false,"has_abstract":false,"ca_institutions":"University of British Columbia","funders":"National Cancer Institute; Novartis Institutes for BioMedical Research; Canadian Breast Cancer Research Alliance; Breast Cancer Alliance","keywords":"Matrix metalloproteinase; Matrix metalloproteinase inhibitor; Drug; Drug development; Cancer research; Pharmacology; Extracellular matrix; Clinical trial; Carcinogenesis; Cancer; Medicine; Bioinformatics; Computational biology; Biology; Cell biology; Internal medicine","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02586750577694744,"score_gpt":0.3782587400899927,"score_spread":0.3523912343130452,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}